David Barr

Venable LLP

+ Follow Contact

Latest Posts › Amgen v Sanofi

Share:

New USPTO Guidelines: After the Supreme Court's Amgen Decision, In re Wands Factors Remain Applicable Enablement Framework

On January 10, 2024, the United States Patent and Trademark Office (USPTO) issued "Guidelines for Assessing Enablement in Utility Applications and Patents in View of the U.S. Supreme Court Decision in Amgen Inc. et al. v....more

1/23/2024 / Amgen v Sanofi , Enablement Inquiries , Intellectual Property Protection , New Guidance , Patent Litigation , Patents , Pharmaceutical Patents , SCOTUS , USPTO

1 Results

View per page

Page: of 1

David Barr

Venable LLP

Popular Topics by This Author

Latest Posts › Amgen v Sanofi

New USPTO Guidelines: After the Supreme Court's Amgen Decision, In re Wands Factors Remain Applicable Enablement Framework

"My best business intelligence, in one easy email…"